“…In part, usage rates may be driven by sociocultural factors, technological advancements, and the widening accessibility of these substances for athletes and the general public [3, 6]. Enduring stigmatisation surrounds AAS use, which can undermine trust in physicians, impair therapeutic programmes and educational initiatives, and amplify the role of non-medical experts [7, 8]. Studies suggest that people who use AAS believe that physicians have limited understanding about these substances, with perceived knowledge levels comparable to that of internet resources and even those who illicitly sell them [8].…”